341 related articles for article (PubMed ID: 9258342)
1. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
Forsten KE; Courant NA; Nugent MA
J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
[TBL] [Abstract][Full Text] [Related]
2. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth.
Ettenson DS; Koo EW; Januzzi JL; Edelman ER
J Cell Physiol; 2000 Jul; 184(1):93-100. PubMed ID: 10825238
[TBL] [Abstract][Full Text] [Related]
3. Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells.
Schmidt A; Skaletz-Rorowski A; Breithardt G; Buddecke E
Eur J Cell Biol; 1995 Jun; 67(2):130-5. PubMed ID: 7664755
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
Sperinde GV; Nugent MA
Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
[TBL] [Abstract][Full Text] [Related]
5. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.
Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M
Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707
[TBL] [Abstract][Full Text] [Related]
6. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
7. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
Nugent MA; Karnovsky MJ; Edelman ER
Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
[TBL] [Abstract][Full Text] [Related]
8. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach.
Gleizes PE; Noaillac-Depeyre J; Amalric F; Gas N
Eur J Cell Biol; 1995 Jan; 66(1):47-59. PubMed ID: 7750519
[TBL] [Abstract][Full Text] [Related]
10. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
11. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
Dodge AB; Lu X; D'Amore PA
J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
[TBL] [Abstract][Full Text] [Related]
12. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
Tumova S; Hatch BA; Law DJ; Bame KJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
[TBL] [Abstract][Full Text] [Related]
14. Regulation by basic fibroblast growth factor of glycosaminoglycan biosynthesis in cultured vascular endothelial cells.
Kaji T; Hiraga S; Ohkawara S; Inada M; Yamamoto C; Kozuka H; Koizumi F
Microvasc Res; 1995 May; 49(3):268-76. PubMed ID: 7643748
[TBL] [Abstract][Full Text] [Related]
15. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor.
Thompson K; Rabinovitch M
J Cell Physiol; 1996 Mar; 166(3):495-505. PubMed ID: 8600153
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 and adrenocorticotropin differentially regulate the synthesis of adrenocortical cell heparan sulfate proteoglycans and their binding of basic fibroblast growth factor.
Jiang Z; Savona C; Chambaz EM; Feige JJ
J Cell Physiol; 1992 Nov; 153(2):266-76. PubMed ID: 1331122
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of large proteoglycan synthesis in cultured smooth muscle cells from pig aorta by endothelial cell-conditioned medium.
Berrou E; Breton M; Deudon E; Picard J
J Cell Physiol; 1991 Dec; 149(3):436-43. PubMed ID: 1744172
[TBL] [Abstract][Full Text] [Related]
20. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK
Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
